SWX/NOVNEE (SWX/NOVNEE)

SIX Swiss Exchange: SWX/NOVNEE · CHF

CHF 132

-2.60 (-1.9%)· Recorded snapshot

Market cap	248.4B
Revenue (ttm)	47.9B
Net income (ttm)	8.4B
EPS (ttm)	CHF 4.37
P/E (trailing)	30.2x
P/E (forward)	16.6x
Volume	130,000
Beta	0.49

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 47.9B
Net income (ttm): 8.4B
EPS (ttm): CHF 4.37
P/E (trailing): 30.2x
P/E (forward): 16.6x
Market cap: 248.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-03 14:30 UTC

Forward P/E16.6

P25 n/aP50 n/aP75 n/a

Trailing P/E30.2

P25 n/aP50 n/aP75 n/a

ROE24.3

P25 n/aP50 n/aP75 n/a

ROIC19.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SWX/NOVNEE indicators

Market & fundamental data

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CHF
Country	Switzerland
Country code	CH
Earnings date	2026-10-27
Employees	75,267
Employees change	-616
Employees growth	-0.81%
Enterprise value	CHF 281.6B
Exchange	SIX Swiss Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1996
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	CH0038459415
Last earnings date	2026-10-27
Last refreshed	2026-11-03
Market cap	CHF 248.4B
Next earnings date	2027-02-03
Price	CHF 131.80
Price currency	CHF
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-02
Symbol	swx/NOVNEE
Website	https://www.novartis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	19.87x
Average P/E ratio (3Y)	17.62x
Average P/E ratio (5Y)	17.8x
Earnings yield	3.31%
EV/Earnings	33.64x
EV/EBIT	17.32x
EV/EBITDA	13.86x
EV/FCF	21.55x
EV/Sales	5.88x
FCF / EV yield	4.64%
FCF yield	5.26%
Forward P/E	16.61x
Graham number	40.76341
Graham upside	-69.07%
Lynch fair value	CHF 22.20
Lynch upside	-83.15%
P/(FCF - SBC) ratio	20.5x
P/(OCF - SBC) ratio	18.39x
P/B ratio	7.93x
P/E ratio	30.19x
P/FCF ratio	19.01x
P/OCF ratio	17.18x
P/S ratio	5.19x
Price/EBITDA ratio	12.37x
Sector forward P/E	19.93x
Sector P/E	34.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.98%
EBITDA margin	41.95%
Effective tax rate	20.8%
FCF margin	27.84%
Gross margin	75.21%
Operating margin	33.98%
Pretax margin	22.04%
Profit margin	17.49%
Profit per employee	CHF 111,194
Profitable quarters	107
Profitable years	28
Revenue per employee	CHF 635,884
ROA	10.86%
ROA (5Y)	7.4%
ROCE	23.04%
ROE	24.33%
ROE (5Y)	23.91%
ROIC	19.26%
ROIC (5Y)	17.5%
SBC / revenue	1.98%
Tax / revenue	4.58%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-28.31%
EPS growth (Q)	-68.81%
EPS growth (QoQ)	-63.16%
EPS growth 10Y	6.32%
EPS growth 3Y	12.03%
EPS growth 5Y	3.87%
EPS growth years	1
FCF growth	-20.02%
FCF growth (Q)	-17.79%
FCF growth (QoQ)	-8.09%
FCF growth 3Y	1.3%
FCF growth 5Y	2.63%
Gross profit growth	0.4%
Gross profit growth (Q)	5.89%
Gross profit growth 3Y	8.64%
Gross profit growth 5Y	3.12%
Net income growth	-30.31%
Net income growth (Q)	-69.4%
Net income growth (QoQ)	-63.17%
Net income growth 3Y	8.58%
Net income growth 5Y	0.45%
Net income growth years	1
OCF growth	-17.79%
OCF growth (Q)	-16.25%
OCF growth (QoQ)	-6.44%
OCF growth 10Y	3.71%
OCF growth 3Y	2.64%
OCF growth 5Y	2.66%
Operating income growth	1.26%
Operating income growth (Q)	16.25%
Operating income growth 3Y	19.41%
Operating income growth 5Y	7.48%
Revenue growth	1.76%
Revenue growth (Q)	4.67%
Revenue growth (QoQ)	0.52%
Revenue growth 10Y	1.46%
Revenue growth 3Y	7.75%
Revenue growth 5Y	1.83%
Revenue growth quarters	1
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CHF -1.4B
Depreciation and amortization	CHF 3.7B
EBIT	CHF 16.3B
EBITDA	CHF 20.1B
EPS	CHF 4.37
Financing cash flow	CHF 649.1M
Free cash flow	CHF 13.1B
Free cash flow minus SBC	CHF 12.1B
Gross profit	CHF 36B
Income taxes	CHF 2.2B
Investing cash flow	CHF -15.6B
Net borrowing	CHF 13.2B
Net cash flow	CHF -572.4M
Net income	CHF 8.4B
Operating cash flow minus SBC	CHF 13.5B
Operating income	CHF 16.3B
Revenue	CHF 47.9B
Stock-based compensation	CHF 947.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.56
Book value per share	CHF 16.45
Debt / EBITDA	1.98
Debt / equity	1.29
Debt / FCF	3.09
Goodwill	CHF 22.2B
Interest coverage	12.36
Long-term assets	CHF 74.2B
Long-term liabilities	CHF 39.8B
Net cash (debt)	CHF -32.9B
Net cash / market cap	-13.25%
Net debt / EBITDA	1.64
Net debt / equity	1.05
Net debt / FCF	2.52
Piotroski F-Score	5
Property, plant and equipment	CHF 10B
Shareholders' equity	CHF 31.3B
Tangible book value	CHF -24.8B
Tangible book value per share	CHF -13.15
Total assets	CHF 97.7B
Total cash	CHF 7.4B
Total debt	CHF 40.3B
Total liabilities	CHF 66.4B
WACC	6.32%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.51
Current assets	CHF 23.5B
Current liabilities	CHF 26.6B
Current ratio	0.88
Inventory turnover	2.27
Net working capital	CHF -2.3B
Quick ratio	0.58
Working capital	CHF -3.2B
Working capital turnover	-12.63

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.76%
Payout ratio	90.4%
Shareholder yield	2.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	70.44%
10Y return CAGR	5.48%
10Y total return	70.44%
150-day SMA	CHF 121.82
1D price change	-1.93%
1M price change	11.66%
1M total return	11.66%
1W price change	3.28%
1W total return	3.28%
1Y price change	33.01%
1Y return CAGR	33.04%
1Y total return	33.01%
20-day SMA	CHF 125.35
200-day SMA	CHF 121.71
3M price change	4.06%
3M total return	4.06%
3Y price change	53.95%
3Y return CAGR	15.47%
3Y total return	53.95%
50-day SMA	CHF 122.31
50-day SMA vs 200-day SMA	50over200
52-week high	CHF 135.22
52-week high date	2026-10-30
52-week low	CHF 99.22
52-week low date	2025-11-04
5Y price change	54.21%
5Y return CAGR	9.05%
5Y total return	54.21%
6M price change	13.52%
6M total return	13.52%
All-time high	CHF 135.22
All-time high date	2026-10-30
All-time low	CHF 50.55
All-time low date	2011-04-26
Average true range (ATR)	CHF 2.55
Average volume	386.5K
Beta (5Y)	0.49
Change from 52-week high	-2.53%
Change from 52-week low	32.84%
Change from all-time high	-2.53%
Change from all-time low	160.73%
Change from open	0.12%
Day's gap	-2.05%
Dollar volume	CHF 17.1M
High price	CHF 132.48
Low price	CHF 131.30
Monthly RSI	66.02
Open price	CHF 131.64
Position in 52-week range	42.37%
Previous close	CHF 134.40
Price vs 150-day SMA	8.19%
Price vs 20-day SMA	5.14%
Price vs 200-day SMA	8.29%
Price vs 50-day SMA	7.76%
Relative volume	0.34
RSI	65.29
Sharpe ratio	1.17
Sharpe ratio (3Y)	0.62
Sharpe ratio (5Y)	0.34
Sortino ratio	1.84
Sortino ratio (3Y)	1.12
Sortino ratio (5Y)	0.75
Volume	130K
Weekly RSI	58.55
YTD price change	20.08%
YTD total return	20.08%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.8B
Shares change (QoQ)	-0.47%
Shares change (YoY)	-2.76%
Shares held by insiders	0.11%
Shares held by institutions	43.86%

Deeper analysis on SWX/NOVNEE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SWX/NOVNEE report

Is a complete SWX/NOVNEE research report available?

No complete published report is available for swx/NOVNEE (SWX/NOVNEE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SWX/NOVNEE (SWX/NOVNEE)

Price

Financial snapshot

Fair-value bridge

Latest news · SWX/NOVNEE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SWX/NOVNEE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SWX/NOVNEE

Frequently asked questions